大塚ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/09/27 | 4,509 | 4,521 | 4,462 | 4,475 | -36 | -0.8% | 672,200 |
| 2017/09/26 | 4,507 | 4,523 | 4,493 | 4,511 | +13 | +0.3% | 1,000,300 |
| 2017/09/25 | 4,559 | 4,565 | 4,486 | 4,498 | -31 | -0.7% | 1,322,900 |
| 2017/09/22 | 4,488 | 4,544 | 4,446 | 4,529 | +71 | +1.6% | 1,936,100 |
| 2017/09/21 | 4,400 | 4,484 | 4,400 | 4,458 | +87 | +2% | 1,342,800 |
| 2017/09/20 | 4,388 | 4,389 | 4,347 | 4,371 | -7 | -0.2% | 1,282,300 |
| 2017/09/19 | 4,375 | 4,399 | 4,363 | 4,378 | +25 | +0.6% | 1,162,600 |
| 2017/09/15 | 4,375 | 4,377 | 4,339 | 4,353 | -21 | -0.5% | 1,527,500 |
| 2017/09/14 | 4,388 | 4,397 | 4,366 | 4,374 | +24 | +0.6% | 939,800 |
| 2017/09/13 | 4,327 | 4,365 | 4,321 | 4,350 | +14 | +0.3% | 1,021,700 |
| 2017/09/12 | 4,424 | 4,424 | 4,330 | 4,336 | -40 | -0.9% | 1,155,400 |
| 2017/09/11 | 4,396 | 4,413 | 4,366 | 4,376 | +50 | +1.2% | 933,200 |
| 2017/09/08 | 4,349 | 4,367 | 4,318 | 4,326 | -32 | -0.7% | 1,885,600 |
| 2017/09/07 | 4,330 | 4,363 | 4,330 | 4,358 | +33 | +0.8% | 1,051,600 |
| 2017/09/06 | 4,308 | 4,338 | 4,290 | 4,325 | +8 | +0.2% | 1,258,200 |
| 2017/09/05 | 4,380 | 4,394 | 4,309 | 4,317 | -52 | -1.2% | 1,114,600 |
| 2017/09/04 | 4,398 | 4,409 | 4,365 | 4,369 | -46 | -1% | 836,400 |
| 2017/09/01 | 4,475 | 4,483 | 4,402 | 4,415 | -14 | -0.3% | 715,200 |
| 2017/08/31 | 4,405 | 4,465 | 4,387 | 4,429 | +24 | +0.5% | 993,400 |
| 2017/08/30 | 4,410 | 4,440 | 4,403 | 4,405 | +5 | +0.1% | 778,800 |
| 2017/08/29 | 4,405 | 4,418 | 4,380 | 4,400 | -41 | -0.9% | 868,600 |
| 2017/08/28 | 4,425 | 4,466 | 4,423 | 4,441 | +27 | +0.6% | 1,113,100 |
| 2017/08/25 | 4,434 | 4,442 | 4,413 | 4,414 | ±0 | ±0% | 682,600 |
| 2017/08/24 | 4,448 | 4,450 | 4,411 | 4,414 | -43 | -1% | 875,500 |
| 2017/08/23 | 4,478 | 4,499 | 4,447 | 4,457 | +5 | +0.1% | 1,046,100 |
| 2017/08/22 | 4,457 | 4,473 | 4,444 | 4,452 | -25 | -0.6% | 760,600 |
| 2017/08/21 | 4,535 | 4,543 | 4,471 | 4,477 | -57 | -1.3% | 757,100 |
| 2017/08/18 | 4,499 | 4,545 | 4,484 | 4,534 | -3 | -0.1% | 1,009,500 |
| 2017/08/17 | 4,549 | 4,552 | 4,522 | 4,537 | -6 | -0.1% | 914,500 |
| 2017/08/16 | 4,520 | 4,555 | 4,458 | 4,543 | +12 | +0.3% | 1,281,700 |
| 2017/08/15 | 4,545 | 4,579 | 4,523 | 4,531 | +2 | ±0% | 1,425,000 |
| 2017/08/14 | 4,583 | 4,590 | 4,523 | 4,529 | -122 | -2.6% | 1,457,800 |
| 2017/08/10 | 4,702 | 4,707 | 4,633 | 4,651 | -73 | -1.5% | 1,612,200 |
| 2017/08/09 | 4,800 | 4,809 | 4,702 | 4,724 | +20 | +0.4% | 1,682,200 |
| 2017/08/08 | 4,825 | 4,833 | 4,646 | 4,704 | -130 | -2.7% | 2,459,500 |
| 2017/08/07 | 4,896 | 4,896 | 4,830 | 4,834 | +26 | +0.5% | 641,400 |
| 2017/08/04 | 4,865 | 4,867 | 4,805 | 4,808 | -71 | -1.5% | 832,800 |
| 2017/08/03 | 4,900 | 4,906 | 4,869 | 4,879 | -31 | -0.6% | 869,600 |
| 2017/08/02 | 4,898 | 4,928 | 4,868 | 4,910 | +61 | +1.3% | 1,196,300 |
| 2017/08/01 | 4,815 | 4,872 | 4,812 | 4,849 | -11 | -0.2% | 730,700 |
| 2017/07/31 | 4,865 | 4,870 | 4,819 | 4,860 | -1 | ±0% | 1,501,500 |
| 2017/07/28 | 4,780 | 4,861 | 4,780 | 4,861 | +55 | +1.1% | 4,788,900 |
| 2017/07/27 | 4,795 | 4,866 | 4,779 | 4,806 | +20 | +0.4% | 2,084,500 |
| 2017/07/26 | 4,751 | 4,786 | 4,746 | 4,786 | +39 | +0.8% | 1,609,900 |
| 2017/07/25 | 4,757 | 4,758 | 4,720 | 4,747 | -5 | -0.1% | 1,027,100 |
| 2017/07/24 | 4,735 | 4,769 | 4,718 | 4,752 | -10 | -0.2% | 1,168,900 |
| 2017/07/21 | 4,790 | 4,801 | 4,751 | 4,762 | -27 | -0.6% | 1,104,200 |
| 2017/07/20 | 4,718 | 4,800 | 4,718 | 4,789 | +85 | +1.8% | 1,156,700 |
| 2017/07/19 | 4,671 | 4,731 | 4,659 | 4,704 | +29 | +0.6% | 1,054,100 |
| 2017/07/18 | 4,780 | 4,787 | 4,671 | 4,675 | -116 | -2.4% | 1,502,600 |
1751～
1800
件表示中 / 3415件
類似銘柄と比較する
現在ご覧いただいている「大塚ＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大塚ＨＤ | 866,300円 | +14.4% | +120.8% | 1.39% | 19.44倍 | 1.78倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| 第一三共 | 464,200円 | +14.3% | +20.1% | 1.29% | 39.01倍 | 5.41倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 409,300円 | +5.1% | +76.2% | 4.79% | 95.41倍 | 0.94倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| アステラス薬 | 156,700円 | +12.2% | +180.3% | 4.72% | 56.10倍 | 1.83倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 212,500円 | +5.7% | +3.9% | 2.70% | 10.57倍 | 1.40倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム
